Zentiva S.A. Logo

Zentiva S.A.

Develops and distributes affordable generic, OTC, and specialty medicines across Europe.

SCD | RO

Overview

Corporate Details

ISIN(s):
ROSCDBACNOR8
LEI:
254900HN31MYF870PE70
Country:
Romania
Address:
THEODOR PALLADY, 032266 BUCUREȘTI, SECTORUL 3
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Zentiva S.A. is a pan-European pharmaceutical company focused on the development, manufacturing, and distribution of high-quality, affordable medicines. The company's extensive portfolio encompasses generic drugs, over-the-counter (OTC) products, and specialty care medicines, including biosimilars. Serving more than 100 million people across over 30 countries, Zentiva is committed to enhancing public health by increasing access to essential treatments. With a workforce of approximately 5,000 employees, the company emphasizes sustainability and social responsibility in its operations, aiming to provide health and wellbeing for all generations.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-15 16:49
Annual Report
Raport Financiar Trimestrial - RFT
English 550.4 KB
2025-05-15 16:47
Quarterly Report
Raport Financiar Trimestrial - RFT
Romanian 648.8 KB
2025-04-30 16:13
Post-Annual General Meeting Information
Raport curent de informare a investitorilor
Romanian 222.1 KB
2025-04-30 13:55
Annual Report
Raport Financiar Anual - RFA
English 819.1 KB
2025-04-30 13:54
Annual Report
Raport Financiar Anual - RFA
Romanian 702.8 KB
2025-02-28 10:30
Annual / Quarterly Financial Statement
REZULTATE FINANCIARE PRELIMINARE
English 262.6 KB
2025-02-28 10:29
Annual Report
REZULTATE FINANCIARE PRELIMINARE
Romanian 334.2 KB
2025-02-21 14:24
Post-Annual General Meeting Information
Convocarea adunarii generale a actionarilor - RC11
Romanian 570.2 KB
2025-02-21 14:02
Post-Annual General Meeting Information
Schimbari in conducerea societatii comerciale - RC09
Romanian 660.1 KB
2024-06-13 16:22
Related Party Transaction
Raportare tranzactii parti afiliate in conformitate cu art.92 ind.3 din Legea 2…
English 128.3 KB
2024-05-15 17:19
Quarterly Report
Raport Financiar Trimestrial - RFT
English 452.7 KB
2024-05-15 17:18
Quarterly Report
Raport Financiar Trimestrial - RFT
Romanian 467.9 KB
2024-04-29 14:28
Post-Annual General Meeting Information
Raport curent de informare a investitorilor
English 111.4 KB
2024-04-29 11:53
Legal Proceedings Report
Litigii in care este implicata societatea comerciala - RC08
English 123.9 KB
2024-03-21 11:05
Pre-Annual General Meeting Information
Convocarea adunarii generale a actionarilor - RC11
English 184.0 KB

Automate Your Workflow. Get a real-time feed of all Zentiva S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Zentiva S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Zentiva S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

PureTech Health plc Logo
A clinical-stage biotherapeutics firm developing new medicines for devastating diseases.
United States of America
PRTC
PURPLE BIOTECH LTD. Logo
Develops first-in-class therapies targeting tumor immune evasion and drug resistance in cancer.
United States of America
PPBT
Pyxis Oncology, Inc. Logo
Developing next-gen ADC and Immuno-Oncology therapeutics for difficult-to-treat cancers.
United States of America
PYXS
PZ Cormay S.A. Logo
Manufactures and distributes IVD reagents and analyzers for human and veterinary medicine.
Poland
CRM
Q32 Bio Inc. Logo
Clinical-stage biotech developing biologic therapies for autoimmune and inflammatory diseases.
United States of America
QTTB
Quantum Biopharma Ltd. Logo
Develops therapies for brain disorders and a functional beverage for post-alcohol wellness.
United States of America
QNTM
Quantum Genomics Logo
Biopharma developing cardiovascular treatments, now in judicial liquidation.
France
ALQGC
QuidelOrtho Corp Logo
Manufactures in-vitro diagnostic tests for at-home, point-of-care, and clinical lab settings.
United States of America
QDEL
Quince Therapeutics, Inc. Logo
Late-stage biotech developing red blood cell-encapsulated drugs for rare diseases.
United States of America
QNCX
Quoin Pharmaceuticals, Ltd. Logo
Clinical-stage pharma developing therapies for rare and orphan diseases like Netherton Syndrome.
United States of America
QNRX

Talk to a Data Expert

Have a question? We'll get back to you promptly.